Analysis of Tks4 Knockout Mice Suggests a Role for Tks4 in Adipose Tissue Homeostasis in the Context of Beigeing by Vas, Virág et al.
cells
Article
Analysis of Tks4 Knockout Mice Suggests a Role for
Tks4 in Adipose Tissue Homeostasis in the Context
of Beigeing
Virag Vas 1,* , Tamás Háhner 1, Gyöngyi Kudlik 1 , Dávid Ernszt 2, Krisztián Kvell 3,
Dániel Kuti 4, Krisztina J. Kovács 4, József Tóvári 5, Mária Trexler 1, Balázs L. Mero˝ 1,
Bálint Szeder 1, Kitti Koprivanacz 1 and László Buday 1,6
1 Institute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences,
1117 Budapest, Hungary
2 Institute of Physiology, Medical School University of Pécs, 7622 Pécs, Hungary
3 Department of Pharmaceutical Biotechnology, Faculty of Pharmacy and Szentagothai Research Center
University of Pécs, 7622 Pécs, Hungary
4 Laboratory of Molecular Neuroendocrinology, Institute of Experimental Medicine, 1083 Budapest, Hungary
5 Department of Experimental Pharmacology, National Institute of Oncology, 1122 Budapest, Hungary
6 Department of Medical Chemistry, Semmelweis University Medical School, 1094 Budapest, Hungary
* Correspondence: vas.virag@ttk.mta.hu; Tel.: +36-20-210-0880
Received: 17 May 2019; Accepted: 30 July 2019; Published: 5 August 2019


Abstract: Obesity and adipocyte malfunction are related to and arise as consequences of disturbances
in signaling pathways. Tyrosine kinase substrate with four Src homology 3 domains (Tks4) is a scaffold
protein that establishes a platform for signaling cascade molecules during podosome formation and
epidermal growth factor receptor (EGFR) signaling. Several lines of evidence have also suggested
that Tks4 has a role in adipocyte biology; however, its roles in the various types of adipocytes at the
cellular level and in transcriptional regulation have not been studied. Therefore, we hypothesized that
Tks4 functions as an organizing molecule in signaling networks that regulate adipocyte homeostasis.
Our aims were to study the white and brown adipose depots of Tks4 knockout (KO) mice using
immunohistology and western blotting and to analyze gene expression changes regulated by the white,
brown, and beige adipocyte-related transcription factors via a PCR array. Based on morphological
differences in the Tks4-KO adipocytes and increased uncoupling protein 1 (UCP1) expression in the
white adipose tissue (WAT) of Tks4-KO mice, we concluded that the beigeing process was more
robust in the WAT of Tks4-KO mice compared to the wild-type animals. Furthermore, in the Tks4-KO
WAT, the expression profile of peroxisome proliferator-activated receptor gamma (PPARγ)-regulated
adipogenesis-related genes was shifted in favor of the appearance of beige-like cells. These results
suggest that Tks4 and its downstream signaling partners are novel regulators of adipocyte functions
and PPARγ-directed white to beige adipose tissue conversion.
Keywords: WAT browning; beige adipocytes; adipogenesis; Tks4 scaffold protein
1. Introduction
Obesity and obesity-related diseases are becoming increasingly common, and while the
obesity-inducing effects of physical inactivity and poor eating habits are well known, other factors
that contribute to the development of obesity and obesity-associated conditions are less clear [1].
Therefore, the molecular and genetic mechanisms governing obesity are intensively studied, with
the goal of improving the management and treatment of obesity-associated diseases [2–4]. Such
studies have identified numerous biochemical factors that control fat storage [5–7] and differences in
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fat depot physiologies [8], with the ultimate goal of developing novel strategies to regulate adipose
tissue homeostasis.
Tks4 (tyrosine kinase substrate with 4 SH3 domains), which is encoded by the Sh3pxd2b
gene, belongs to the “positive regulation of adipose tissue development” gene ontology group
(GO:1904179) [9]. Tks4 is a scaffold protein that modulates several cellular signaling pathways by
bringing regulatory proteins, kinases, and actin-organizing structures into close proximity [10]. Tks4
is involved in podosome formation, cell migration, mesenchymal stem cell differentiation, and bone
trabecular formation [11–14]. Homozygous mutation of Sh3pxd2b can lead to the rare genetic disease
Frank-ter Haar syndrome (FTHS, OMIM:249420) [15], which affects several tissues due to the defect of
Tks4. This disease is characterized by bone abnormalities, such as kyphosis and craniofacial deformities,
cardiac disease due to valve or septal defects, glaucoma, and in some cases low adipose tissue depot
weight [15–17]. Loss of Tks4 has recently also been shown to disturb bone formation, ultimately
leading to osteoporosis [18].
Tks4 has also been linked to adipocyte biology, as the protein was initially named FAD49
(factor for adipocyte differentiation 49) and was proposed to be a novel factor that played “a crucial
role in the immediate early stage of adipocyte differentiation” [19]. Experiments with the 3T3-L1
preadipocyte cell line showed that the FAD49 mRNA expression level increases during the induction
of adipogenesis and that preadipocytes with silenced FAD49 expression do not properly accumulate
lipid droplets. In addition to in vitro experiments, animal studies have also demonstrated that Tks4
expression is altered in obesity-related model systems. For example, compared to its status in healthy
animals, the Tks4-encoding gene is hypomethylated and transcriptionally upregulated in the inguinal
white adipose tissue of diet-induced obese mice [9]. Another analytical study that measured the
transcriptome/methylome profile of a fatty pig strain during the fat deposition period identified
the Tks4-encoding gene as a “candidate intermuscular fat deposition gene” [20]. Some findings
have suggested that Tks4 is also potentially important in human adipocyte biology. Arner et al.
demonstrated that the methylation and expression patterns of Sh3pxd2b are altered in the white adipose
tissue (WAT) of insulin-resistant and insulin-sensitive women [21]. Furthermore, Tks4 mRNA is
expressed in human adipose-derived stem cells isolated from the stromal vascular fraction (SVF) of
abdominal lipoaspirates [22]. A role for Tks4 in adipocyte differentiation was also suggested by one of
our previous studies, in which we showed that mesenchymal stem cells isolated from the bone marrow
of Tks4 mutant mice had reduced in vitro adipogenic differentiation potential [14]. Although we have
some knowledge of the involvement of Tks4 in adipocyte biology, the cellular roles of Tks4 in different
types of adipose tissues and its effects on transcriptional regulation have not been described.
Adipose tissue consists of at least three types of metabolically distinct adipocytes: white, beige,
and brown [23,24]. While the classical white fat adipocytes are specialized in synthesizing triglycerides
and storing them in the form of lipid droplets, brown adipocytes are responsible for heat production
and thermoregulation via their ability to uncouple respiration on the mitochondrial membrane and to
dissipate chemical energy via UCP1. The third type of adipocyte, brown-like fat cells (also referred to as
beige cells), have been found in WAT [25]. During WAT “browning” or “beigeing”, the UCP1 expression
level is elevated, and adipocytes containing several lipid droplets appear among the unilocular white
fat cells [26]. This phenomenon can be observed after cold exposure or upon adrenergic stimulus.
Recently, several genes have been identified as genetic regulators of beigeing [27,28], and their effects
on WAT beigeing have been confirmed in mouse models [25,29]. In addition to various types of
adipocyte cells, adipose depots (ADs) also consist of preadipocytes, adipose tissue stem cells, pericytes,
endothelial cells, fibroblasts, and macrophages [30]. The cellular compositions of ADs located in
different anatomical sites vary, and the specific composition determines the main function of a given
AD [8,31].
To identify the roles of Tks4 in adipocyte homeostasis, we analyzed the WAT depots and brown
adipose tissue (BAT) of Tks4 knockout (Tks4-KO) mice. We found that in Tks4-deficient WAT cells the
adipocyte size was significantly reduced and the number of beige fat cells was increased compared
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to these features in wild-type (WT) WAT. Furthermore, by measuring the adipogenesis-regulated
gene expression signature in WAT from Tks4-KO animals, we found that a loss of Tks4 led to altered
expression levels of PPARγ transcriptional targets.
Therefore, we propose that the Tks4 scaffold protein plays a role in white adipocyte beigeing and
that it is a novel regulator of beige cell differentiation.
2. Materials and Methods
2.1. Animal Studies
The animal procedures in this study were conducted under the approval of the Institutional Animal
Ethics Committee (approval number: PEI/001/2042-6/2014), and the currently valid institutional and
national guidelines for the care and use of animals were followed. Mice were maintained and handled
in accordance with the Guidelines for Accommodation and Care of Animals (European Convention
for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes). The
Tks4-KO mice (in the C57Bl/6 genetic background) were originally developed by TaconicArtemis
GmbH (Cologne, Germany) [14,18]. The fifth and sixth coding exons of the Sh3pxd2b gene were flanked
by loxP sites, and the floxed exons were then excised via Cre-mediated recombination in the germ
line, resulting in inactivation of the Sh3pxd2b gene. Tks4-KO mice are infertile: thus, for experiments,
heterozygous animals were crossed in every generation to produce Tks4-deficient animals along with
their WT littermates. The genotype of each littermate was determined using a previously described
genomic PCR method [14]. Western blotting was used to test for the presence of Tks4 protein in various
tissue types, including skeletal muscle, heart muscle, brain, lung, spleen, and adipose tissue, and the
complete removal of the fifth and sixth exons of Sh3pxd2b was confirmed previously in the Tks4-KO
mice [14]. As we demonstrated in our previous study, the Tks4 protein is undetectable in the tissues of
our Tks4-KO mice. Age-, strain-, and sex-matched genotypically WT and Tks4−/− mice were used in
this study.
2.2. EchoMRI Measurement
WT and Tks4-KO mice were weighed at the ages of 3–4 months and 7 months. In vivo analyses of
their lean body mass, fat mass, and water content were performed in conscious, restrained mice via
nuclear magnetic resonance imaging (MRI) (EchoMRI, whole body composition analyzer; E26-233RM,
Echo Medical Systems, Houston, TX, USA).
2.3. Western Blotting
WT and Tks4-KO mice were euthanized, and interscapular BAT (iBAT), gonadal WAT (gWAT),
and subcutaneous WAT (sWAT) samples were removed and stored at −80 ◦C until further processing.
The frozen samples were homogenized with a Potter-Elvehjem Tissue Grinder and lysed in ice cold
30 mM Tris buffer (pH 7.5) containing 100 mM NaCl; 1% Triton X-100, 10 mM NaF; 1 mM EGTA; 1 mM
Na3VO4; 2 mM p-nitrophenyl-phosphate; 10 mM benzamidine; 1 mM phenylmethylsulphonyl fluoride
(PMSF); and 25 µg/mL each of Pepstatin A, trypsin inhibitor, and aprotinin. The adipocyte lysates
were clarified via centrifugation at 14,000 rpm for 10 min at 4 ◦C twice to remove the pellet and the
fat layer. Sample buffer (4x, 0.2 M Tris, 0.277 M SDS, 40% (v/v) glycerol, 0.588 M β-mercaptoethanol,
0.05 M EDTA, and 1.19 mM bromophenol blue in distilled water) was then added to the clear
protein suspension, and the samples were boiled for 3 min. Equal amounts of each sample were
subjected to SDS-PAGE using 7.5% running gels. The proteins were then transferred to polyvinylidene
difluoride (PVDF) membranes and blocked. The membranes were incubated at room temperature for
60 min with the relevant primary antibody. Polyclonal anti-Tks4-specific antibodies were generated
previously [32]. The anti-α-tubulin (DM1A) and anti-UCP1 (u6382) antibodies were obtained from
Sigma-Aldrich (St. Louis, MO, USA). The anti-adiponectin (C45B10) antibody was obtained from
Cell Signaling Technology (Danvers, MA, USA). After several washing steps, the membranes were
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treated with horseradish peroxidase-conjugated secondary antibodies (GE Healthcare, Little Chalfont,
Buckinghamshire, UK) for 30 min and then washed again. The reacting antigens were visualized
with enhanced chemiluminescence (ECL) detection reagents from Amersham Life Sciences Limited
(Buckinghamshire, UK).
2.4. Immunohistochemical Analysis and Quantification
WT and Tks4-KO mice were euthanized, and BAT, gWAT, and sWAT samples were removed
and stored in formalin solution at 4 ◦C. The fat tissue samples were embedded in paraffin and then
sectioned at a thickness of 2 µm. Serial sections were cut and then stained with hematoxylin and eosin
(H & E) or subjected to immunohistochemistry. The samples were first deparaffinized in xylene and
then hydrated in a series of aqueous alcohol solutions. The sections were treated with H2O2 to block
the endogenous peroxidase activity, and antigen retrieval was performed via heat mediation. The
slides were then incubated in protein-blocking solution (Sniper Blocking Solution; Biocare Medical,
Pacheco, CA 94553, USA) followed by an overnight incubation at 4 ◦C with rabbit polyclonal anti-UCP1
primary antibody (u6382, Sigma). The sections were then incubated in Mach 2 Rabbit HRP Polymer
(Biocare Medical) as the secondary antibody, and colorimetric detection was performed with AEC
(3-amino-9-ethylcarbazole). The immunostained sections were counterstained with hematoxylin.
Negative control specimens from the experimental mice were treated in the same way but without
primary antibodies. In any case, no background staining was observed. The stained sections were
digitally scanned with a Panoramic 250 Flash II high-resolution scanner (3DHISTECH Ltd., Budapest,
Hungary). The UCP1 expression pattern and lipid droplet size distribution were quantified in four
defined-size fields-of-view per slide by annotating them with CaseViewer 2.1 software (3DHISTECH
Ltd., Budapest, Hungary). HistoQuant software (3DHISTECH Ltd., Budapest, Hungary) was used for
the histological evaluations.
2.5. Cell Isolation, Analysis, and Culture
10–14-week-old Tks4−/− and WT mice were euthanized, and sWAT, gWAT, and iBAT fat pads
were isolated, minced, and incubated in digestive medium containing 0.1% (m/v) (for sWAT and
gWAT) or 0.2% (m/v) (for iBAT) type IV collagenase in Dulbecco’s phosphate-buffered saline (all
from Sigma-Aldrich) for 1 h at 37 ◦C on a shaker. The tissue digestion was stopped by adding an
equal volume of fetal bovine serum (FBS), and the resulting cell suspensions were centrifuged twice
at 300× g for 5 min in Hank’s balanced salt solution (HBSS) (all from Invitrogen, Carlsbad, CA,
USA) to isolate the stromal vascular fraction (SVF). The pellets containing the SVF were resuspended
in cell culture medium consisting of 10% FBS, 5% horse serum (Invitrogen), 50 U/mL penicillin,
50 µg/mL streptomycin (Sigma-Aldrich), and 2 mM l-glutamine (Invitrogen) in Dulbecco’s Modified
Eagle Medium (DMEM)/Ham’s F-12 medium (Life Technologies, Carlsbad, CA, USA). SVF cells were
seeded into 6-well plates (VWR, Radnor, PA, USA) at a density of 4 × 104 cells/cm2, and the cultures
were grown to confluency in a humidified incubator at 37 ◦C with 5% CO2. Confluent cultures
were digested and seeded in triplicate into 24-well plates (VWR) for adipogenic induction. During
adipogenic induction, the cultures were treated for 7 days with adipogenic medium containing 10% FBS,
0.5 mM 3-isobutyl-1-methylxanthine (Sigma-Aldrich), and 0.1 µM dexamethasone (Sigma-Aldrich) in
DMEM/Ham’s F-12 supplemented with 50 U/mL penicillin and 50 µg/mL streptomycin. On day 7, the
cultures were fixed with 10% formalin for 20 min at 4 ◦C and then stained with Oil Red O (Sigma Aldrich)
and dimethylmethylene blue. Lipid droplet accumulation was visualized via photographs collected
using a digital camera (Nikon Coolpix 4500, Tokyo, Japan) connected to an inverted microscope
(Olympus CK2). During osteogenic induction, the cultures were treated for 14 days in osteogenic
medium containing 10% FBS, 10 mM β-glycerophosphate (Sigma-Aldrich), 50 µg/mL ascorbic acid
(Sigma), and 0.01 µM hydrocortisone (Sigma-Aldrich) DMEM (Life Technologies) supplemented with
50 U/mL penicillin and 50µg/mL streptomycin. On day 14, the cultures were fixed with 10% formalin for
20 min at 4 ◦C and then stained with Alizarin Red S (Sigma-Aldrich). Calcium deposition was assessed
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via images collected with a digital camera (Nikon Coolpix 4500) connected to an inverted microscope
(Olympus CK2). The SVF isolation and osteogenic and adipogenic differentiation experiments were
repeated twice, and SVF samples from three mice in each group were pooled for each time point. Oil
Red O stain accumulation was quantified via ImageJ according to the method of Deutsch et al. [33].
The Oil Red O-positive area was measured in 5–14 fields-of-view per SVF sample at 10× magnification.
2.6. Adipogenesis-Regulated Gene Expression PCR Array
WT and Tks4-KO mice were euthanized, and gWAT samples were removed and stored at −80 ◦C
before RNA extraction. The RNeasy Microarray Tissue Mini Kit (cat. no. 73304, Qiagen, Hilden,
Germany) was used to isolate total RNA according to the manufacturer’s instructions. On-column
DNase-treatment was included to eliminate potential genomic DNA contamination. RNA samples
were reverse-transcribed to produce cDNA using the RT2 First Strand Kit following the manufacturer’s
instructions (cat. no. 33041, Qiagen).
A Mouse Adipogenesis RT2 Profiler PCR Array (PAMM-049ZA, Qiagen) was used for precise gene
expression profiling following the manufacturer’s instructions. This array simultaneously measures
the expression levels of 84 adipogenesis-related genes. The transcripts and their acronyms are provided
in Table S1. The adipogenesis array supports the parallel use of five housekeeping genes (β-actin,
β2-microglobulin, Gapdh, β-glucorunidase, Hsp90ab1) for accurate normalization and to exclude the
presence of genomic DNA contamination. The PCR plates were run on an HT7500 platform, and the
results were analyzed online using RT2 Profiler PCR Array Data Analysis software (SABioscience).
The ∆∆CT method was used for relative quantification. To calculate the fold changes (increases and
decreases), the gene expression levels measured in the Tks4-KO samples were normalized to the
expression levels in WT samples. During the normalization step, the values from the WT samples were
set to 1. During differentiation, small changes in the expression levels of genes encoding transcription
factors have large effects on the outcome of the tightly regulated fate decision. Thus, genes were
considered to be differentially expressed when the fold change in either direction was >1.5 (fold change
cut-off, F > 1.5). Data were collected from two Tks4-KO and two WT samples, and the results are
represented on a logarithmic scale. The differentially expressed genes were grouped according to
their gene ontology similarities and clustered into pro-adipogenic, anti-adipogenic, and pro-brown
functional groups [34]. We extracted the PPARγ target genes from the differentially expressed genes
with the help of the PPARgene database, which lists the experimentally verified and computationally
predicted PPARγ target genes [35]. The Adipogenesis Regulation Network database (ARN) was used
to visualize the network of interacting factors [36].
2.7. Statistical Analysis
All of the results are presented as the mean ± SEM. Differences between two experimental groups
(WT versus Tks4−/−) were compared using unpaired Student’s t-tests. Graphpad Prism version 5.0
software was used for the statistical analysis, and the differences were considered statistically significant
when p < 0.05.
3. Results
3.1. Absence of the Tks4 Protein Resulted in Altered Adipose Tissue Composition
3.1.1. Phenotypic Description of the Three Adipose Depots in Tks4-KO Mice
To investigate the roles of Tks4 in adipose tissue, we used Tks4 knockout mice. The Tks4-KO
strain was generated in the C57Bl/6 background via targeted disruption of the Tks4-encoding gene
Sh3pxd2b, resulting in the complete loss of the Tks4 protein [14]. The Tks4-KO mice had reduced fat
mass at each tested time point as measured via EchoMRI, indicating a stable lipodystrophy condition
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(Figure 1A). We further analyzed the levels of Tks4 protein in the different adipose depots in the WT
mice and found that Tks4 was expressed in the gWAT, sWAT, and iBAT (Figure 1B).
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Figure 1. Adipogenic phenotypes of the Tks4-knockout (KO) mice. (a) Fat mass and lean body mass
of 3–4- and 7-month-old wild-type (WT) and Tks4-KO mice as measured via EchoMRI. The numbers
within the white columns indicate the normalized fat mass to body mass percentage. (b) Western
blot-based detection of Tks4 in WT gonadal white adipose tissue (gWAT), subcutaneous WAT (sWAT),
and interscapular brown adipose tissue (iBAT). Tubulin was used as the loading control. Representative
hematoxylin and eosin (H & E)-stained (c) gWAT, (d) sWAT, and (e) iBAT sections from WT and
Tks4-KO mice are shown on the left side. Scale bar: 20 µm. The arrow indicates a multilocular cell
islet among the white adipocytes in the Tks4-KO gWAT. Lipid droplet sizes were quantified, and size
distribution diagrams are presented on the right side. Sections of six WT and six Tks4-KO mice were
used, and four different fields-of-view from each mouse were analyzed. All data are presented as the
mean ± SEM, and t-tests were applied to test statistical significance. * indicates p < 0.05.
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We next asked whether the adipocyte morphology was altered in the Tks4-KO mice compared to
the WT animals. Hematoxylin–eosin (H & E) staining revealed an obvious decrease in adipocyte size
in the gWAT and sWAT of the Tks4-KO mice (Figure 1C,D). Interestingly, the unilocular adipocyte
population in the gWAT was accompanied by multilocular cells that resembled beige adipocytes
(Figure 1C). In contrast, compared to the BAT of WT animals, the BAT of the Tks4-KO mice exhibited
larger lipid droplets and larger adipocytes, and more unilocular white adipocyte-like cells were present
in the mutant animals (Figure 1E). As reported previously for WT mice, we also observed that the
adipocytes were significantly larger in gWAT than in sWAT [37]. Based on the adipose tissue phenotypes
of the Tks4-KO mice, we hypothesized that Tks4 has a yet uncovered role in adipocyte biology.
3.1.2. Tks4-KO and WT Stromal Vascular Fraction (SVF) Cells Shared a Similar De Novo
Adipogenic Potential
A link is thought to exist between fat cell size and de novo adipogenesis [37,38]. The presence
of smaller adipocytes can indicate a population of not fully mature cells that might have originated
from a disturbed progenitor/stem cell pool with enhanced differentiation potential [39,40]. Therefore,
to assess the differentiation potential of Tks4-KO stem/progenitor cells, WT and Tks4-KO SVF cells
were examined to determine whether the decreased adipocyte size in the Tks4-KO mice was due to
an altered supply of adipocytes in the WAT. SVF cells were isolated from the three adipose depots,
and adipogenic differentiation was induced in the precursor cells in vitro. To assess the presence of
stem/progenitor cells in the SVF, we also induced osteogenic differentiation in the SVF cells. The
Tks4-KO and WT adipocyte precursors from all three adipose depots showed similar adipogenic and
osteogenic differentiation potential (Figure 2B, Figure S1). As previously reported by others for WT
SVF, we also observed that the most robust adipocyte accumulation occurred in the sWAT cultures,
and SVF cells isolated from gWAT formed the fewest lipid droplet-containing committed adipocytes
(Figure 2A). Taken together, these results show that a loss of Tks4 caused a size reduction specifically
in white adipocytes accompanied by the appearance of morphologically “beige-like” multilocular cells,
without an effect on the overall supply of the adipocyte population.
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Figure 2. The adipogenic differentiation capacity of stromal vascular fraction (SVF) cells. (a) SVF
cells isolated from gWAT, sWAT, and iBAT from WT and Tks4-KO mice were treated with adipogenic
medium for 7 days and then stained with Oil Red O to visualize the lipid droplets and dimethyl
methylene blue to stain the cytoplasm. Representative images (original magnification: 10×) and (b)
quantification of the Oil Red O staining.
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3.1.3. UCP1 Expression Was Higher in Tks4-KO WAT Than in WT WAT
The histological observation that Tks4-KO gWAT contained small adipocytes and beige-like cells
suggests that the white adipocytes in Tks4-KO mice might undergo browning-like differentiation.
Therefore, the expression levels of UCP1, a well-accepted marker associated with brown and beige
adipocytes, were measured [41]. Immunohistochemical (IHC) analyses of the different depots revealed
that the UCP1 expression level was higher in the Tks4-KO WAT than in the WT WAT (Figure 3A,B). In
the WT samples, the UCP1 expression level was lower in the gWAT than in the sWAT, and, as expected,
the highest UCP1 expression was detected in the iBAT [42]. Surprisingly, the UCP1 protein level in
the Tks4-KO iBAT was lower than that in the wild-type iBAT, as demonstrated via IHC (Figure 3B).
The UCP1 protein level in the iBAT samples reached the detection threshold of the western blot assay,
which made it possible to confirm that the total UCP1 protein level in the Tks4-KO iBAT was lower
than that in the WT iBAT (Figure 3C,D).
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Tks4-KO and WT mice. We used the RT2 Profiler PCR Adipogenesis Array to measure the 
expression levels of 84 key genes involved in adipocyte differentiation [43] and five reference genes 
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the expression patterns of pro-adipogenic factors, anti-adipogenic factors and pro-brown 
Figure 3. Adipogenic phenotypes of Tks4-KO mice. (a) Representative images of uncoupling protein 1
(UCP1)-stained gWAT, sWAT, and iBAT sections isolated from WT and Tks4-KO mice. Scale bar: 50 µm.
(b) Quantification of the UCP1+ frequency. Sections from six WT and six Tks4-KO mice were analyzed,
and four different fields-of-view from each tissue sample were included. All data are presented as the
mean ± SEM, and t-tests were applied to test statistical significance. * indicates p < 0.05. (c) Western
blot analysis of the UCP1 protein abundance in iBAT isolated from WT and Tks4-KO mice. Tubulin
was used as the loading control. A representative blot of two WT and two Tks4-KO iBAT samples is
shown. (d) Quantification of the UCP1 western blotting results for the iBAT samples isolated from four
WT and four Tks4-KO mice from two independent experiments.
3.2. Loss of Tks4 Resulted in an Altered Gene Expression Pattern in White Adipocytes
3.2.1. Results of the Adipogenesis-Regulated Gene Expression PCR Array
To learn more about the role of the Tks4 scaffold protein in the WAT beigeing phenotype, we
perform d a quantitative mRNA expression analysis of adipogenesis-related nes. As the gonadal
depot presented more abundant multilocular beige-like cells and the most pronounced increase
in UCP1 abun ance among the white adipose depots, we further characterized the gWAT of both
Tks4-KO and WT mice. We used th RT2 Profiler PCR Adipogenesis Array to measure the expression
Cells 2019, 8, 831 9 of 16
levels of 84 key genes involved in adipocyte differentiation [43] and five reference genes as internal
controls (Table S1, Figure 4A). As suggested by the array manufacturer, we grouped the differentially
expressed genes based on their functions during adipogenesis and separately analyzed the expression
patterns of pro-adipogenic factors, anti-adipogenic factors and pro-brown differentiation factors. The
expression levels of the genes belonging to the pro-adipogenic group were downregulated in the
Tks4-KO white adipose depot (Figure 4B). In parallel, the expression levels of the anti-adipogenic
factors were elevated in the Tks4-KO mice, suggesting that the classical white adipocyte differentiation
process was affected in the absence of Tks4 (Figure 4C). Next, marker genes specific to brown and beige
adipocyte differentiation were analyzed. We observed increased expression levels of factors belonging
to the pro-browning functional group. Interestingly, the expression levels of Prdm16 and PPARγc1a, the
two key beige transcription factors, were also elevated [44,45]. The Ucp1 mRNA expression level was
also increased in the Tks4-KO white adipose depot, as expected based on the IHC data (Figure 3A–D).
3.2.2. The Differentially Expressed Adipogenesis-Related Genes Formed A Network with PPARγ as Its
Central Regulator
Adipogenesis is driven by a series of transcription factor-regulated signaling pathways; thus,
we performed a network analysis on the differentially expressed gene set [36]. Out of the list of
differentially expressed genes, 28 were present in the Adipogenesis Regulation Network database
(ARN) and could be placed in an interaction network diagram (Figure 4E). The network visualization
of the relationships between the signaling molecules revealed that the PPARγ adipogenic transcription
factor was the most highly connected node. It is well documented that positive and negative regulatory
effects converge on PPARγ and that the outcome of the signaling program depends on the balance of
these effects [46]. PPARγ, together with its coactivators and corepressors, regulates the expression of
several adipogenesis-promoting genes [47] therefore, the expression levels of PPARγ target genes can
be used as an indicator to predict the outcomes of the synergistic and antagonistic signals [48]. As
shown in Figure 4F, the predicted and validated PPARγ target genes were grouped together, and their
expression levels were analyzed [35]. The expression levels of most of the PPARγ target genes were
downregulated, including CEBpd, Lpl, Lipe, and Adipoq, and notably, these genes function in white
adipocytes [49]. In contrast, the highly expressed PPARγ target genes belong to the brown-specific
marker gene group [48] (Figure 4F). We concluded that the outcome of the convergent signaling
program centered around PPARγ was shifted in favor of the appearance of beige-like cells among the
white adipocyte population.
The gene expression changes detected via the adipogenesis array were validated via western
blotting. Nevertheless, it must be considered that the protein levels of the transcription factors are
very low and that measuring their levels via western blotting requires a large amount of tissue lysate.
Moreover, the isolation of sufficient amounts of protein from the reduced gWAT in the Tks4-KO mice is
technically challenging. Therefore, the adipokine adiponectin was chosen as the reference protein for
the western blot validation, as it is relatively abundant in normal adipose tissue and is easily detectable
via western blotting. Adiponectin was present in the WT gWAT samples but was mostly undetected
in the Tks4-KO gWAT, confirming the results of the adipogenic array, which showed reduced Adipoq
mRNA expression in the Tks4-KO gWAT (Figure 4g).
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(a) Scatter plot showing the up- and r lation of the investigated gene set. Each dot r presents
the expression level of a given gene in T g AT (the x axis represents the WT ∆CT) and in Tks4-KO
gWAT (the y axis represents the Tks4-KO ∆CT). The two black lines represent the threshold fold change
cut-offs at ±1.5. The black lines demarcate the genes with unchanged expression levels (blue dots), and
the red-labeled and green-labeled dots represent the up- and downregulated genes, respectively, in the
Tks4-KO gWAT (see the gene list in Table S1). The relative expression levels of the genes belonging to the
pro-adipogenic factor group (b), the anti-adipogenic factor group, (c) and the pro-brown factor group
(d) are shown in separate plots. The blue circles highlight a cofactor (PPARγC1a) and a corepressor
(Sirt1) of PPARγ. The expression levels of the genes marked with red circles were verified via western
blotting and immunohistochemical (IHC) analysis. The mRNA levels measured in the WT samples
were set to 1, and the fold changes in the gene expression levels in the Tks4-KO samples were calculated.
(e) An interaction network of the differentially regulated genes. The black arrows represent activating
relationships, and the blunt-end lines represent inhibitory relationships among the factors. The red
arrow indicates PPARγ as the most highly connected node. (f) The relative gene expression levels of
the PPARγ-targeted genes. The gene expression fold changes were calculated via the ∆∆CT method.
(g) The adiponectin protein level was measured via western blotting to validate the change in the
mRNA level detected on the array. The adiponectin protein level was measured in three WT and three
Tks4-KO gWAT samples, and tubulin was used as the loading control.
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4. Discussion
The formation of beige cells in WAT has been observed in several transgenic mouse strains with a
lean, reduced-adiposity phenotype [34,50]. In this study, we collected histological and gene expression
data that provided evidence of WAT browning accompanied by a reduced body fat percentage in
Tks4-KO mice.
Silva et al. suggested that adipocyte homeostasis is influenced by the functions of adipose stem
cells: therefore, we isolated the stem cell-enriched SVF from Tks4-KO and wild-type mice and compared
their capacities for in vitro differentiation [51,52]. We identified phenotypic alterations that are specific
to anatomically distinct WAT depots [37,39], as demonstrated by the observation that gWAT-derived
SVF cells have a lower adipogenic potential compared to sWAT-derived SVF cells [53–55]. We also
showed that the adipogenic differentiation potential of the adipocyte precursors in the Tks4-KO SVF
was similar to that of the WT cells. These data are inconsistent with the observation that silencing Tks4
mRNA expression in 3T3-L1 cells can block adipogenic differentiation in vitro [19]. These seemingly
conflicting results possibly stem from the fact that the SVF consists of a heterogeneous cell population
that includes preadipocytes, vascular endothelial cells, pericytes, and adipose tissue mesenchymal
stem cells while 3T3-L1 fibroblast cultures represent a homogeneous cell population that originate from
a single clone. Therefore, the diverse population of SVF cells might form adipogenesis-supportive
microenvironments in vitro and in vivo in conjunction with the extracellular matrix [56], which could
rescue the adipogenic differentiation potential of the Tks4-KO preadipocytes. In synchronized 3T3-L1
fibroblast cell lines, the lack of Tks4 and the absence of supportive niche cells resulted in defective
adipocyte development [19].
Our data also showed prominent gWAT beigeing in Tks4-KO mice relative to the WT mice.
Several groups focusing on sWAT have reported a more prominent beige potential in sWAT compared
to in gWAT. However, it has also been reported, at least in some cases, that the gWAT depot has a
pronounced beigeing phenotype, as has also been published for PDE3B KO mice [57].
Based on the histological examinations and UCP1 expression level measurements, we propose
that the WAT of Tks4-KO mice undergoes a partial conversion to beige fat. To further confirm the
involvement of the Tks4 protein in the regulation of adipocyte biogenesis, the gene expression profile
of a panel of adipogenesis-regulating factors was measured [58]. This analysis revealed that the gene
expression pattern was altered in the Tks4-KO mice and that the signaling pathways underlying the
beigeing process were more pronounced in these animals than in the WT animals. In the Tks4-KO
gWAT, the expression levels of an adipogenesis-supporting gene set tended to be downregulated,
while the expression levels of a browning-selective gene set tended to be upregulated. Based on
a network visualization generated using the ARN database [36], we found that the differentially
expressed genes formed a network and that PPARγ was the central regulator of the included signaling
pathways. The PPARγ transcription factor, together with its cofactors, regulates the transcription
of several adipogenesis-related genes [45]. PPARγ coactivators, such as the SWI/SNF (mating type
switching/sucrose nonfermenting) complex, enhance the transcription of adipogenesis-promoting
genes [48]. In contrast, other cofactors (e.g., PPARγC1a) and corepressors (e.g., Sirt1) bind to PPARγ
to enhance the expression of several browning-related target genes [59–61]. Of note, increased
PPARγC1a expression was observed in the TKS4-KO gWAT, further supporting the notion that
PPARγ-driven gene expression was shifted in favor of the browning differentiation process over the
regular white adipocyte differentiation process (Figure 4D). Moreover, the expression level of the
Sirt1 corepressor was also higher in the absence of the Tks4 protein, which could have potentially
resulted in the inhibition of PPARγ-mediated transcription of adipogenesis-related genes (Figure 4C).
Modification of the transcriptional activity of PPARγ by several cofactors subsequently led to increased
or decreased expression levels of its target genes [48]. Therefore, to reveal how the expression levels of
PPARγ target genes are regulated in the Tks4-KO mice, we entered the gene list from the adipogenic
array into a database of PPARγ target genes [35]. As shown in Figure 4F, the expression levels of
browning-promoting PPARγ target genes were upregulated (Dio2, Sirt3). In contrast, the expression
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levels of white adipocyte-specific PPARγ target genes were downregulated (Lpl, Lipe, Retn, Cebpd).
Based on our results, we propose that the loss of Tks4 leads to changes in multiple cellular signaling
pathways that contribute to the fine-tuning of PPARγ-regulated transcription in adipocytes.
We also demonstrated that compared to the WT iBAT, the TKS4-KO iBAT had lower UCP1
expression and an increased lipid droplet size, and such alterations could lead to defective BAT
function. During this study, we focused on the roles of Tks4 in white and beige adipocyte biology;
however, it would also be interesting to study the roles of Tks4 in constitutive brown fat cells. Based on
the altered WAT beigeing and the BAT-related phenotypes in TKS4-KO mice, we propose the hypothesis
that the formation of beige adipocytes is enhanced in the WAT of Tks4-KO mice as a compensatory
mechanism for ineffective BAT cell function. A similar compensatory WAT browning due to impaired
BAT function was reported in Bmpr1a mutant mice by Schulz at al. [62]. Our hypothesis that an
alternative thermogenic beigeing process may be recruited to compensate for altered iBAT function in
Tks4-KO mice warrants further examination.
Recently, some data have suggested a positive correlation between BAT function and bone
mass [63–66], indicating that a direct or indirect relationship exists between bone remodeling and
brown adipocyte biology. Therefore, it is important to point out that the reduced iBAT size in the
Tks4-KO mice [14] was accompanied by an osteoporotic-like bone phenotype [18]. Furthermore, Tks4
has already been identified as a regulator of osteogenic differentiation in BM-MSCs [14]: therefore, the
relationship between bone porosity and the altered BAT phenotype identified in this model system is
intriguing, and it supports the notion of an interdependence between brown adipocyte function and
bone homeostasis.
A better understanding of the mechanisms by which mouse beige adipocytes differentiate in WAT
might suggest potential points of intervention relevant in the fight against obesity and obesity-related
diseases. It should be noted that mouse models of obesity have limitations, given that several aspects
of human obesity differ from those of rodents. Furthermore, different conclusions may arise from
mouse and human studies because of differences in the anatomical distribution of fat pads [40], the
variant adipocyte composition of BAT [7,8], or the different aging-related changes in the size of the BAT
in humans and mice [67,68]. Nevertheless, mouse obesity research is an important and useful tool for
gaining insight into mechanisms that govern adipocyte homeostasis that are conserved across species.
Therefore, there are growing research efforts to describe brown and beige adipocyte biology and to
understand the intersection between mouse and human obesity research [40]. Since it has been shown
that cold exposure causes common physiological changes in WAT that lead to adipocyte beigeing in
both mice and humans, the use of mouse models could be instrumental in clarifying the mechanism
underlying white to beige adipocyte conversion. Based on the results of this study, we propose that
Tks4 and its downstream signaling partners are important regulators of adipose tissue homeostasis in
the context of beigeing, and our results enhance our understanding of adipocyte browning. However,
the translation of Tks4-KO mouse data into targeting Tks4 in human cases for pharmacological obesity
therapy requires further studies.
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